Multi-Year Contract Extension with Nycomed for Genedata Screener

Number of Users for Genedata Lead Discovery Solution Expected to Double

Basel, Switzerland, January 10, 2008

Genedata, a leading provider of in silico solutions for drug discovery, today announced a multi-year contract extension for the use of the Genedata Screener® lead discovery product suite with Nycomed, a global manufacturer of innovative pharmaceuticals. Taking a trusted collaboration to the next level, Genedata will create a global scientific computing infrastructure for the lead discovery and drug research programs at Nycomed sites worldwide.

Independent of instrumentation, technology, volume or location, Genedata Screener will enable the interdisciplinary teams at all sites to rapidly capture, visualize, analyze and manage large volumes of assay data. Low to ultra-high throughput screens, single-point assays or complex high content screens will all benefit from Screener`s high performance and flexibility. The effective combination of these findings with data from other corporate sources, accessible through Screener`s powerful and easy to use viewing tools, will provide Nycomed scientists with the range of information they need to enhance their lead finding processes – anywhere on the globe.

Dr. Werner Stürmer, Head of HTS at Nycomed, explained, “Genedata Screener not only improves the efficiency and quality of our screening campaigns, but also has a catalytic impact on our global information network – increasing the number of users and promoting accurate and timely decisions across departments and countries. “

Dr. Stephan Heyse, Head of the Genedata Screener Business Unit, added, “Our high performance and advanced quality control capabilities together with the established professional services and low maintenance cost will help to ease time constraints and to streamline communication, while generating high-quality results.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. www.genedata.com

Contact
Allison Kurz
Genedata
Marketing & Communications
Phone: +41 61 511 8459
communications@genedata.com

Jackie Thrasivoulos
Genedata
Public Relations
Phone: +1 508 881 3109
jackie.thrasivoulos@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.